BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2544310)

  • 1. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
    Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
    Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution TLC mapping and characterization of 32P-postlabeled monophosphate 7,12-dimethylbenz[a]anthracene-DNA adducts.
    Yang PF; Randerath K
    Carcinogenesis; 1990 Jan; 11(1):159-64. PubMed ID: 2104782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion.
    Maccubbin AE; Lee L; Struck RF; Gurtoo HL
    Chem Biol Interact; 1992 Sep; 84(1):21-35. PubMed ID: 1394614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered fidelity of a nucleic acid modifying enzyme, T4 polynucleotide kinase, by safrole-induced DNA damage.
    Randerath K; Gupta KP; van Golen KL
    Carcinogenesis; 1993 Aug; 14(8):1523-9. PubMed ID: 8102596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV; Gupta RC; Randerath E; Randerath K
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC; Reddy MV; Randerath K
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
    Reddy MV; Irvin TR; Randerath K
    Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC; Earley K
    Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC enrichment of hydrophobic DNA--carcinogen adducts for enhanced sensitivity of 32P-postlabeling analysis.
    Dunn BP; San RH
    Carcinogenesis; 1988 Jun; 9(6):1055-60. PubMed ID: 3286027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV; Smith CV; Randerath E; Randerath K
    Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S; Kim SY; Suzuki N
    Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts.
    Reddy MV
    Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and identification of benzo[a]pyrene-DNA adducts by [35S]phosphorothioate labeling and HPLC.
    Lau HH; Baird WM
    Carcinogenesis; 1991 May; 12(5):885-93. PubMed ID: 2029754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ring-opened 7-methylguanine nucleotides are resistant to nuclease P1 digestion and good substrates to polynucleotide kinase.
    Hemminki K
    Carcinogenesis; 1989 Sep; 10(9):1761-3. PubMed ID: 2548753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved high-performance liquid chromatography analysis of 32P-postlabeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adducts using in-line precolumn purification.
    Mauthe RJ; Marsch GA; Turteltaub KW
    J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):91-101. PubMed ID: 8998575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.